Enovis (ENOV) Non-Current Deferred Tax Liability (2010 - 2011)
Enovis (ENOV) reported Non-Current Deferred Tax Liability of $13.1 million for Q4 2011, down 2.84% year-over-year from $13.5 million in Q4 2010, and down 17.47% quarter-over-quarter from $15.9 million in Q3 2011.
Enovis (ENOV) Non-Current Deferred Tax Liability (2010 - 2011) Analysis & Trends
Enovis (ENOV) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $13.1 million in Q4 2011.
- Non-Current Deferred Tax Liability for Q4 2011 came in at $13.1 million, down 2.84% year-over-year; the trailing twelve-month figure through Dec 2011 was $13.1 million (down 2.84% YoY), and the FY2011 annual result was $13.1 million, down 2.84% from the prior year.
- Non-Current Deferred Tax Liability retreated to $13.1 million in Q4 2011 per ENOV's latest filing, from $15.9 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $16.7 million in Q3 2011 and troughed at $13.1 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 13.15 Mn |
| Dec 31, 2011 | 13.15 Mn |
| Sep 30, 2011 | 15.93 Mn |
| Sep 30, 2011 | 15.93 Mn |
| Jul 1, 2011 | 16.71 Mn |
| Jul 1, 2011 | 16.71 Mn |
| Dec 31, 2010 | 13.53 Mn |
| Dec 31, 2010 | 13.53 Mn |